Trial Profile
Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide (50/250) Over 12 Weeks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms VIA-CONTROL
- Sponsors GlaxoSmithKline; GSK
- 08 May 2008 New trial record.